HSF1 and cancer: In recent years, more and more studies on m6A in cancer have reported that β-catenin stimulates m6A modification and subsequent translation of HSF1 mRNA by inhibiting miR455-3p production; thus, targeting HSF1 may be a potential therapeutic strategy to intervene in cancers5.